TransMedics' GAAP loss for six months of 2021 was $18.585 million, up 7.1% from $17.349 million in the prior year. Revenue increased 39.4% to $15.224 million from $10.921 million a year earlier.
TransMedics' GAAP loss for six months of 2021 was $18.585 million, up 7.1% from $17.349 million in the prior year. Revenue increased 39.4% to $15.224 million from $10.921 million a year earlier. 
English (US) 